- 产品描述
- 产品组分
- 文件资源
- 营销中心
- 注意事项
- FAQ
- 文献追踪
-
Anti-CoV2RBD-cas-mIgG2a and Anti-CoV2RBD-imd-mIgG2a have been generated by recombinant DNA technology, produced in CHO cells, and purified by affinity chromatography, ensuring lot-to-lot reproducibility. Furthermore, these mAbs have been functionally validated by ELISA (see data below). The absence of bacterial contamination has been confirmed by cellular assays.

Background
Casirivimab和Imdevimab是用人源化小鼠和康复患者[1]生成的。 这些单克隆抗体特异性靶向SARS-CoV-2 S-RBD的两个不同且不重叠的区域,并有效阻断其与靶细胞上ACE2受体的结合 [1].
应用类型
- 采用类似ELISA的方法来检测培养上清液或血清中是否存在SARS-CoV-2
- 流式细胞术结合分析
- 开发针对SARS-CoV-2的中和抗体
- 监测SARS-CoV-2 变体逃逸
质控
- 使用来自SARS-CoV-2变体的包被Spike-RBD蛋白,通过ELISA进行功能验证
SARS-CoV-2 Spike-RBD proteins (3 μg/ml) derived from the Wuhan (A), United Kingdom (U.K.) (B), or South-Africa (S.A.) (C) variants were coated on ELISA plates overnight. A 3-fold serial dilution of Anti-CoV2RBD-imd-IgG2a (red curve), Anti-CoV2RBD-cas-mIgG2a (orange curve), CR3022-derived Anti-Spike-RBD mIgG2a (back curve), of Anti-βGal-mIgG2a antibodies (grey curve) was performed for the capture step. A HRP-labelled Anti-mIgG2a antibody (1/1000 dilution) and the HRP substrate OPD (o-phenylenediamine dihydrochloride) were used for the detection step. Absorbance was read at 490 nm.References
1. Hansen J. et al., 2020. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science 369:1010-1014.
2. Weinreich D.M. et al., 2021. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. N Engl J Med. 384(3):238-251.
3. https://www.fda.gov/media/145610/download.
4. https://www.ema.europa.eu/en/news/ema-issues-advice-use-regn-cov2-antibody-combination-casirivimab-imdevimab.
5. Baum A. et al., 2020. REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters. Science 370:1110-1115.关键词:- Anti-CoV2RBD-imd-mIgG2a(Imdevimab-derived)
-
产品组分
组分内容
型号
规格 价格 储存温度
Anti-CoV2RBD-imd-mIgG2a(Imdevimab-derived)
srbdc4-mab10
100ug 4785.00